Aspects of the co-ordination chemistry of the antiviral nucleotide analogue, 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP)

被引:37
作者
Blindauer, CA
Sjåstad, TI
Holy, A
Sletten, E
Sigel, H
机构
[1] Univ Basel, Inst Inorgan Chem, CH-4056 Basel, Switzerland
[2] Univ Bergen, Dept Chem, N-5007 Bergen, Norway
[3] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CZ-16610 Prague, Czech Republic
来源
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS | 1999年 / 21期
关键词
D O I
10.1039/a904838c
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The acidity constants of the twofold protonated, acyclic, antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine, H-2(PMEDAP)(+/-), as well as the stability constants of the M(H;PMEDAP)(+) and M(PMEDAP) complexes with the metal ions M2+=Mg2+, Ca2+, Sr2+, Ba2+, Mn2+, Co2+, Ni2+, Cu2+, Zn2+ or Cd2+, have been determined by potentiometric pH titrations in aqueous solution at I=0.1 M (NaNO3) and 25 degrees C. Application of previously determined straight-line plots of log K-M(R-PO3(M)) versus pK(H(R-PO3)(H)) for simple phosph(on)ate ligands and comparisons with previous results obtained for the nucleobase-free compound (phosphonomethoxy)ethane, PME, and its derivative, PME-R, where R represents a nucleobase residue without an affinity for metal ions, show that the primary binding site of PMEDAP(2-) is the phosphonate group with all the metal ions studied and that also in all instances 5-membered chelates involving the ether oxygen of the -CH2OCH2PO32- chain are formed. The position of the isomeric equilibria between these chelates, M(PMEDAP)(cl/O), and the 'open' complexes, M(PMEDAP)(op), is determined. In the M2+/PMEDAP(2-) systems with Co2+, Ni2+, Cu2+, and most likely also Zn2+, a third isomer is formed which was detected by comparing the stabilities of the M(PMEDAP) and M(PME-R) complexes; this additional stability enhancement has to be attributed to the 2,6-diaminopurine residue. General considerations as well as H-1 NMR line broadening studies with Cu2+ reveal that in this third isomer a macrochelate is formed in which the phosphonate-bound metal ion interacts in addition with N7 of the purine residue, M(PMEDAP)(cl/N7). The equilibria involving the three isomers are described and quantified; e.g. 19 (+/- 3)% of Cu(PMEDAP) exists as an isomer with a sole phosphonate co-ordination, 38 (+/- 11)% as Cu(PMEDAP)(cl/O) and 43 (+/- 11)% as Cu(PMEDAP)(cl/N7). The corresponding numbers of Ni(PMEDAP) are 33 (+/- 6)% (open), 13 (+/- 8)% (cl/O) and 54 (+/- 10)% (cl/N7). The open and the macrochelated isomers resemble in their structure the corresponding complexes formed by the parent nucleotide adenosine 5'-monophosphate (AMP(2-)). The possible interrelation between the structure of the metal ion complexes in solution and the antiviral properties of PMEDAP and related compounds is discussed.
引用
收藏
页码:3661 / 3671
页数:11
相关论文
共 81 条
[41]   PHOSPHORYLATION OF 9-(2-PHOSPHONOMETHOXYETHYL)ADENINE AND 9-(S)-(3-HYDROXY-2-PHOSPHONOMETHOXYPROPYL)ADENINE BY AMP(DAMP) KINASE FROM L1210 CELLS [J].
MERTA, A ;
VOTRUBA, I ;
JINDRICH, J ;
HOLY, A ;
CIHLAR, T ;
ROSENBERG, I ;
OTMAR, M ;
HERVE, TY .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (10) :2067-2077
[42]  
MILDVAN AS, 1987, MAGNESIUM, V6, P28
[43]  
MILDVAN AS, 1990, MET IONS BIOL SYST, V26, P1
[44]   9-(2-PHOSPHONYLMETHOXYETHYL)-2,6-DIAMINOPURINE (PMEDAP) - A NOVEL AGENT WITH ANTI-HUMAN IMMUNODEFICIENCY VIRUS ACTIVITY INVITRO AND POTENT ANTI-MOLONEY MURINE SARCOMA-VIRUS ACTIVITY INVIVO [J].
NAESENS, L ;
BALZARINI, J ;
ROSENBERG, I ;
HOLY, A ;
DECLERCQ, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (12) :1043-1047
[45]  
Naesens L, 1997, ANTIVIR CHEM CHEMOTH, V8, P1
[46]   ACTIVITY OF THE ANTI-HIV AGENT 9-(2-PHOSPHONYL-METHOXYETHYL)-2,6-DIAMINOPURINE AGAINST CYTOMEGALOVIRUS IN-VITRO AND IN-VIVO [J].
NEYTS, J ;
STALS, F ;
BRUGGEMAN, C ;
DECLERCQ, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (06) :437-446
[47]   MECHANISM OF ACTION OF ACYCLIC NUCLEOSIDE PHOSPHONATES AGAINST HERPES-VIRUS REPLICATION [J].
NEYTS, J ;
DECLERCQ, E .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (01) :39-41
[48]   Crystal structures of human DNA polymerase beta complexed with DNA: Implications for catalytic mechanism, processivity, and fidelity [J].
Pelletier, H ;
Sawaya, MR ;
Wolfle, W ;
Wilson, SH ;
Kraut, J .
BIOCHEMISTRY, 1996, 35 (39) :12742-12761
[49]   POLYMERASE STRUCTURES AND MECHANISM [J].
PELLETIER, H .
SCIENCE, 1994, 266 (5193) :2025-2026
[50]   FORMATION OF COMPLEXES BY PYRIMIDINE DERIVATIVES .11. FORMATION CONSTANTS OF SOME COPPER(II) COMPLEXES WITH PURINE AND PYRIMIDINE [J].
REINERT, H ;
WEISS, R .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1969, 350 (11) :1310-+